Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Neonatal

When a mminant is bom, it consumes colostmm within a few hours. Colostmm contains antibodies from the mother s milk that serve to immunize the neonate against disease (37). These antibodies can be absorbed by the neonate only within the first few days of its life there is no placental transfer of antibiotics in mminants (37). [Pg.157]

The mmen is not functional at birth and milk is shunted to the abomasum. One to two weeks after birth, the neonate consumes soHd food if offered. A calf or lamb that is nursing tends to nibble the mother s feed. An alternative method of raising the neonate is to remove it from its mother at a very young age, <1 week. A common example of an early weaning situation is the dairy calf that is removed from the cow soon after birth so that the cow s milk supply might be devoted entirely to production. In this instance, the neonate requires complete dietary supplementation with milk replacer. Sources of milk replacer protein have traditionally included milk protein but may also include soybean proteins, fish protein concentrates, field bean proteins, pea protein concentrates, and yeast protein (4). Information on the digestibiUty of some of these protein sources is available (4). [Pg.157]

By approximately 8 weeks after birth, the mminant has developed a fully functional mmen capable of extensive fermentation of feed nutrients (4). The rate of development of the mminal environment depends on the amount of milk consumed by the neonate in relation to its growth requirements, the avadabihty and consumption of readily digestible feedstuffs, and the physical form of the feedstuffs (4). The mmen develops much faster with hay than with milk (36). Concentrates, ie, high cereal grain diets, increase the absorptive surface of the mmen but mminal size and musculature develops much more slowly with a concentrate diet than with a forage diet (4). [Pg.157]

The demonstration that injected or force-fed neonatal rodents given extremely high doses of MSG showed evidence of brain lesions, has led to much additional research to determine any possible link between neurotoxicity and human use of MSG (33). However, no evidence from animal tests indicates that MSG in the diet causes brain damage in humans (34). [Pg.305]

Florfenicol (2) has been approved in Japan for the treatment of pseudo-tuberculosis caused by Pasteurellapiscicida and streptococcosis m. yeUowtail fish. The recommended dose is 10 mg/kg for up to one week and the drug withdrawal time is five days after cessation of treatment. Florfenicol is active in bovine respiratory disease caused by Pasteurella species and mastitis caused by Staphylococci and Streptococci. It is also effective in neonatal cohbacillosis caused by E. coli. The drug is being developed worldwide by Schering-Plough Animal Health for the treatment of aquatic and bovine diseases. [Pg.515]

Respiratory Syncytial Virus. Respiratory syncytial vims (RSV) causes severe lower respiratory tract disease in infants. It is the major cause of hospitalization in the United States (- 90,000 events/yr) and it has a high mortaUty rate in neonates and other high risk populations, such as the geriatric population (51). Development of an RSV vaccine has always been a major priority, however, earlier attempts have mostiy failed (70). [Pg.359]

Herpes Simplex. There are two types of herpes simplex vims (HSV) that infect humans. Type I causes orofacial lesions and 30% of the U.S. population suffers from recurrent episodes. Type II is responsible for genital disease and anywhere from 3 x 3 x 10 cases per year (including recurrent infections) occur. The primary source of neonatal herpes infections, which are severe and often fatal, is the mother infected with type II. In addition, there is evidence to suggest that cervical carcinoma may be associated with HSV-II infection (78—80). [Pg.359]

Environmental exposures to PCBs are significantly lower than those reported in the workplace and are therefore unlikely to cause adverse human health effects in adults. However, it is apparent from the results of several recent studies on children that there was a correlation between in utero exposure to PCBs, eg, cord blood levels, and developmental deficits (65—68) including reduced bkth weight, neonatal behavior anomaUes, and poorer recognition memories. At four years of age, there was stiU a correlation between prenatal PCB exposure levels and short-term memory function (verbal and quantitative). In these studies the children were all exposed to relatively low environmental levels of PCBs. Although these effects may be related to other contaminants, it is clear that this is an area of concern regarding the potential adverse human health impacts of PCBs. [Pg.66]

Bihmbin oxidase [80619-01 -8] derived from Mjrothecium verrucaria was modified with polyethyleneglycol when this conjugate was injected intravenously to jaundiced rats, the plasma bihmbin dropped to normal levels. This approach might have potential in the treatment of hyperbihmbinemia, fulminant hepatitis, and neonatal bihmbin encephalopathy (177). [Pg.312]

Figure 1 The major hormones involved in growth and funetion of the fetal/neonatal testis illustrating how exogenous, environmental oestrogens eould disrupt the normal balanee of these meehanisms. Figure 1 The major hormones involved in growth and funetion of the fetal/neonatal testis illustrating how exogenous, environmental oestrogens eould disrupt the normal balanee of these meehanisms.
Figure 2 Key events in fetal/neonatal life whieh predetermine reproduetive funetion of the adult human male. Note that the Sertoli eells are involved in the orehestration and eo-ordination of all of the key events. The relationship between the key events indieated and disorders of male reproduetive development and funetion are indieated in boxes. Figure 2 Key events in fetal/neonatal life whieh predetermine reproduetive funetion of the adult human male. Note that the Sertoli eells are involved in the orehestration and eo-ordination of all of the key events. The relationship between the key events indieated and disorders of male reproduetive development and funetion are indieated in boxes.
Zaccolo M, Pozzan T (2002) Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295 1711-1715... [Pg.4]

In agreement with abundant mRNA in mammary gland, high levels of apelin are present in bovine colostrum oral intake of apelin might modulate immune responses in neonates [4]. [Pg.204]


See other pages where Neonatal is mentioned: [Pg.664]    [Pg.151]    [Pg.157]    [Pg.520]    [Pg.192]    [Pg.270]    [Pg.237]    [Pg.122]    [Pg.307]    [Pg.437]    [Pg.312]    [Pg.2]    [Pg.62]    [Pg.64]    [Pg.87]    [Pg.94]    [Pg.96]    [Pg.98]    [Pg.98]    [Pg.99]    [Pg.99]    [Pg.100]    [Pg.101]    [Pg.105]    [Pg.108]    [Pg.114]    [Pg.130]    [Pg.131]    [Pg.132]    [Pg.133]    [Pg.133]    [Pg.103]    [Pg.322]    [Pg.206]    [Pg.129]    [Pg.199]    [Pg.233]    [Pg.233]   
See also in sourсe #XX -- [ Pg.8 , Pg.10 , Pg.13 , Pg.15 , Pg.17 , Pg.86 ]

See also in sourсe #XX -- [ Pg.12 , Pg.14 , Pg.15 , Pg.16 , Pg.23 , Pg.36 , Pg.38 , Pg.39 , Pg.40 , Pg.42 , Pg.44 , Pg.46 , Pg.47 , Pg.49 , Pg.50 , Pg.138 ]

See also in sourсe #XX -- [ Pg.131 , Pg.189 ]

See also in sourсe #XX -- [ Pg.96 , Pg.100 , Pg.197 , Pg.230 , Pg.302 ]

See also in sourсe #XX -- [ Pg.468 , Pg.1394 ]

See also in sourсe #XX -- [ Pg.256 ]




SEARCH



Absorption neonatal animals

Active sleep, neonates

Acute neonatal presentation

Acute neonatal presentation diagnosis

Adrenoleukodystrophy, neonatal

Adult Consequences of Neonatal REM Sleep Deprivation

Alkaline phosphatase neonates

Amino acid neonatal

Antimicrobials neonatal animals

Antinociception action in neonate rats

Anuria neonatal

Application of Nonisotopic Immunoassay to Neonatal Screening

Autoantibodies neonatal lupus

Benign familial neonatal convulsions

Benign neonatal epilepsy

Blood gases neonatal

Bovine neonates

Brazelton Neonatal Behavior Assessment

Brazelton Neonatal Behavior Assessment Scales

Cardiac neonatal

Chloramphenicol in neonates

Cholestasis neonatal

Chromaffin cells neonatal

Congenital heart block, neonatal lupus

Conjunctivitis neonatal

Contrast neonates

Cystic fibrosis, neonatal screening

Dietary and neonatal hemochromatosis

Does Mitochondrial Inhibition Mimic the Hypoxia-Induced Receptor Potential in Neonatal Chromaffin Cells

Drug metabolism neonatal

Ductus arteriosus, patent neonatal

EXOSURF Neonatal

Excretion neonatal animals

Fetal/neonatal lungs

Foals neonatal

Foreskin, neonatal

Furosemide neonates

Genetic screening neonatal

Glucose neonatal

Goats neonatal animals

Haemochromatosis neonatal

Haemorrhage, neonatal

Horses neonatal animals

Hyperbilirubinemia, neonatal

Hyperbilirubinemia, neonatal treatment

Hyperthyroidism neonatal

Hypoglycemia, neonatal

Hypotension neonatal

Hypothyroidism, neonatal immunoassay

Idiopathic neonatal hepatitis

In neonates

Iodine deficiency neonate

Kidneys neonatal animals

Larvae sensitivity, neonate

Learning human neonate

Lung injury neonatal

Manganese neonates

Medicine neonatal/perinatal

Meningitis neonatal

NICU (neonatal intensive care

Necrotizing enterocolitis, neonatal

Neonatal 6-OHDA and recovery of function

Neonatal Administration

Neonatal Fc receptor

Neonatal Hypoglycemia and the Importance of Gluconeogenesis

Neonatal Placental barrier

Neonatal RSD

Neonatal Research

Neonatal abstinence syndrome

Neonatal animals

Neonatal animals distribution

Neonatal animals metabolism

Neonatal animals, blood-brain barrier

Neonatal aortic thrombosis

Neonatal behavioural assessment scale

Neonatal bilirubin

Neonatal brain

Neonatal cardiac myocytes

Neonatal complications

Neonatal deaths

Neonatal defects

Neonatal development

Neonatal development immunity

Neonatal diabetes mellitus

Neonatal erythrocytes

Neonatal exposure

Neonatal flow sensors

Neonatal goiter

Neonatal goitre

Neonatal haemochromatosi

Neonatal health

Neonatal hyperbilirubinaemia

Neonatal hypothyroidism

Neonatal intensive care

Neonatal intensive care unit

Neonatal intestinal obstruction

Neonatal jaundice

Neonatal lesions

Neonatal lung disease

Neonatal mouse

Neonatal mouse model

Neonatal outcome measures

Neonatal period

Neonatal rat AMC

Neonatal rat ventricular myocyte

Neonatal respiratory distress

Neonatal respiratory distress syndrome

Neonatal respiratory distress syndrome prevention

Neonatal screening

Neonatal screening phenylketonuria

Neonatal seizure

Neonatal sepsis, treatment

Neonatal serum

Neonatal serum enzymes

Neonatal subjects

Neonatal teratogenicity

Neonatal tolerization

Neonatal toxicity

Neonatal tyrosinemia

Neonatal tyrosyluria

Neonatal withdrawal

Neonatal-rat stratum comeum

Neonate gonococcal ophthalmia

Neonate sensitivity

Neonate sensitivity plants

Neonate with Congenital Heart Disease

Neonate, hypoglycemia

Neonates

Neonates Chlamydia infections

Neonates adverse reactions

Neonates aminoglycosides

Neonates and pediatric patients

Neonates anesthetic agents

Neonates antimicrobial therapy

Neonates biliary function

Neonates blood lead levels

Neonates blood-brain barrier

Neonates body composition

Neonates bronchopulmonary dysplasia

Neonates caffeine elimination

Neonates calcium metabolism

Neonates cytomegalovirus infections

Neonates definition

Neonates dose determination

Neonates dosing interval

Neonates drug absorption

Neonates drug clearance

Neonates drug distribution

Neonates drug metabolism

Neonates drug withdrawal

Neonates encephalitis

Neonates excipients

Neonates gastric

Neonates haemochromatosis

Neonates haemorrhage

Neonates hemorrhagic disease

Neonates herpes infections

Neonates hyperinsulinism

Neonates hyperthyroidism

Neonates hypothyroidism

Neonates illness

Neonates immunity

Neonates intensive care medication errors

Neonates intramuscular drug absorption

Neonates iodine requirements

Neonates lead exposure

Neonates liver abnormalities

Neonates necrotizing enterocolitis

Neonates opioid withdrawal

Neonates oral drug absorption

Neonates parenteral nutrition

Neonates participation

Neonates pharmacokinetics

Neonates phenobarbital

Neonates phenytoin

Neonates plasma protein binding

Neonates primidone

Neonates quiet sleep

Neonates renal drug elimination

Neonates renal drug excretion

Neonates syndrome)

Neonates synthase

Neonates thyroid deficiency

Neonates thyroid function

Neonates thyroid hormone levels

Neonates thyroid hormones role

Neonates tocolytics

Neonates vaccination

Neonates with hypothyroidism

Neonates, human

Neonates, ketone bodies

Neonates. REM sleep deprivation

Neonates/infants

Neonates/newborns

Neonates/newborns depression

Neonates/newborns hypothyroidism

Neonates/newborns infections

Neonates/newborns premature

Neurotoxicants and Neonates

New Understandings of Neonatal Sleep-Wake States

Oxidation in neonates

Parenteral nutrition neonatal aluminium

Pediatric groups neonates

Peroxisomal disorders neonatal

Phototherapy, neonatal jaundice

Plasma amino acids neonatal

Plasma sodium neonatal

Pulmonary hypertension neonatal

Respiratory distress syndrome, neonates

SPECIAL POPULATIONS Neonates

Serum bilirubin neonatal

Serum thyroxine neonatal

Sheep neonatal animals

Skeletal muscles neonatal

Thyroid-stimulating hormone neonatal

Thyroxine neonatal

Tissues neonatal

Transient neonatal diabetes mellitus

Transient neonatal hypothyroidism

Ultrasound neonatal kidney

© 2024 chempedia.info